Yueh-Shan Weng Selected Research

tanshinone

1/2015

Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yueh-Shan Weng Research Topics

Disease

10	Neoplasms (Cancer) 01/2024 - 01/2007
5	Neoplasm Metastasis (Metastasis) 01/2024 - 08/2022
4	Hepatocellular Carcinoma (Hepatoma) 05/2023 - 08/2020
3	Cardiomegaly (Heart Hypertrophy) 10/2020 - 01/2012
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2008 - 01/2007
2	Triple Negative Breast Neoplasms 05/2023 - 09/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2022 - 09/2021
2	Hypertrophy 10/2020 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 05/2020
2	Inflammation (Inflammations) 12/2017 - 04/2009
2	Fibrosis (Cirrhosis) 12/2017 - 01/2012
1	Glioblastoma (Glioblastoma Multiforme) 05/2023
1	Glioma (Gliomas) 01/2023
1	Adenocarcinoma of Lung 08/2022
1	Osteosarcoma (Osteogenic Sarcoma) 08/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Heart Diseases (Heart Disease) 01/2012
1	Asthma (Bronchial Asthma) 04/2009
1	Carcinoma (Carcinomatosis) 07/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 05/2023 - 12/2017
3	magnololIBA 05/2023 - 05/2020
3	ErbB Receptors (EGF Receptor)IBA 05/2023 - 08/2020
2	Phosphotransferases (Kinase)IBA 01/2023 - 08/2020
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 08/2020
2	regorafenibIBA 09/2021 - 08/2020
2	CalcineurinIBA 10/2020 - 01/2015
2	Estrogen ReceptorsIBA 10/2020 - 01/2015
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 10/2020 - 01/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017 - 09/2008
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Janus KinasesIBA 05/2023
1	lenvatinibIBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	IsotopesIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 09/2022
1	fucoidanIBA 09/2022
1	olaparibIBA 09/2022
1	Adenosine (Adenocard)FDA LinkGeneric 09/2022
1	Polysaccharides (Glycans)IBA 09/2022
1	Therapeutic UsesIBA 09/2022
1	AMP-Activated Protein KinasesIBA 09/2022
1	B7-H1 AntigenIBA 09/2022
1	diphenyl (biphenyl)IBA 08/2022
1	NF-kappa B (NF-kB)IBA 08/2022
1	Cisplatin (Platino)FDA LinkGeneric 09/2021
1	Pemetrexed (MTA)FDA Link 09/2021
1	dan-shen root extractIBA 10/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2020
1	Epidermal Growth Factor (EGF)IBA 08/2020
1	Biphenyl CompoundsIBA 05/2020
1	AntibodiesIBA 01/2019
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019
1	CytokinesIBA 01/2019
1	CollagenIBA 12/2017
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2017
1	galanginIBA 12/2017
1	Atrial Natriuretic Factor (ANF)IBA 01/2015
1	transcription factor NF-AT c3IBA 01/2015
1	tanshinoneIBA 01/2015
1	Mannose (D-Mannose)IBA 01/2012
1	Histones (Histone)IBA 01/2012
1	Salmeterol Xinafoate (Serevent)FDA Link 04/2009
1	sodium sulfite (sodium sulphite)IBA 04/2009
1	Air Pollutants (Pollutants, Air)IBA 04/2009
1	Fluticasone (Cutivate)FDA LinkGeneric 04/2009
1	Interleukin-8 (Interleukin 8)IBA 04/2009
1	SulfitesIBA 04/2009
1	montelukast (Singulair)FDA Link 04/2009
1	diallyl disulfide (diallyl disulphide)IBA 09/2008
1	ethyl 2-(N-m-chlorobenzyl- (2'-methyl)) anilino- 4- oxo- 4,5- dihydrofuran- 3- carboxylateIBA 07/2007
1	rheinIBA 01/2007

Therapy/Procedure

3	Therapeutics 01/2024 - 01/2012
1	Immunotherapy 01/2024
1	Radiotherapy 01/2023
1	Oral Administration 09/2022